Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.
CEO: |
Sarah Jennifer Howell |
CFO: |
David Ellam |
Non-Executive Director: |
Alan Edward Smith |
Non-Executive Chairman: |
Andrew Richards |
Independent Non-Executive Director: |
Mohammed Sohail Fazeli, Christine Helen Soden, Jeremy Lewis Morgan |
Address: |
Chesterford Research Park, Little Chesterford, Saffron Walden, United Kingdom |
Phone: |
+44 (0)1223 426060 |
Fax: |
|
Website: |
https://arecor.com/ |
Email: |
|